Cargando…
Clinical Relationship between Cholestatic Disease and Pituitary‐Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series
BACKGROUND: A high prevalence of cholestatic disease, including gallbladder mucocele (GBM), has been reported in dogs with naturally occurring pituitary‐dependent hyperadrenocorticism (PDH). HYPOTHESIS/OBJECTIVES: Differences exist in the clinical features of dogs with PDH and concurrent cholestatic...
Autores principales: | Kim, K.‐h., Han, S.‐m., Jeon, K.‐o., Kim, H.‐t., Li, Q., Ryu, M.‐o., Song, W.‐j., Park, S.‐c., Youn, H.‐y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354004/ https://www.ncbi.nlm.nih.gov/pubmed/28064467 http://dx.doi.org/10.1111/jvim.14608 |
Ejemplares similares
-
Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020) -
Relationship of serum leptin concentration with pituitary‐dependent hyperadrenocorticism and cholestatic disease in dogs
por: Lee, S., et al.
Publicado: (2019) -
Comparison of Survival Times for Dogs with Pituitary‐Dependent Hyperadrenocorticism in a Primary‐Care Hospital: Treated with Trilostane versus Untreated
por: Nagata, N., et al.
Publicado: (2016) -
Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
por: García San José, Paula, et al.
Publicado: (2020) -
Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021)